Tell us what you think about Healio

  • News Wire Alerts
  • RSS Feeds
  • Endocrinology

Loading...

  • Sign in for a personal experience.

    Customized content served to meet your interests.

  • All Specialties
  • Endocrinology
  • Subspecialties
    • All Endocrinology
    • Adrenal
    • Bone/Mineral Metabolism
    • Cardiometabolic Disorders
    • Diabetes
    • Diabetes Education
    • Hormone Therapy
    • Neuroendocrinology
    • Obesity
    • Pediatric Endocrinology
    • Practice Management
    • Reproduction/Androgen Disorders
    • Thyroid
    • Type 2 Diabetes Resource Center
  • All Specialties
  • Adolescent Medicine
  • Allergy/Immunology
  • Cardiology
  • Dermatology
  • Endocrinology
  • Gastroenterology
  • Geriatric Medicine
  • Health Professions
  • Hematology/Oncology
  • Hepatology
  • Infectious Disease
  • Nursing
  • Ophthalmology
  • Optometry
  • Orthopedics
  • Orthotics/Prosthetics
  • Pediatrics
  • Psychiatry
  • Rheumatology
  • Sports Medicine
  • News
    • All News
    • News Publications
    • Endocrine Today
    • Publication Exclusives
    • Meeting News Coverage
  • Video
  • Blogs
    • All Blogs
    • Michael Kleerekoper MD MACE
    • Thomas B Repas DO FACP FACE CDE
  • Education Lab/CME
    • Education Lab Home
    • CME
  • Books
  • Meetings
    • Meetings/Courses
    • Meeting News Coverage
  • Careers

Healio › Endocrinology › Hormone Therapy › News

  • In the Journals
  • Rapid decline in ovarian cancer rates coincides with decreased hormone therapy use

  • May 22, 2013
  • The decrease in ovarian cancer rates in the United States accelerated after a marked decline in use of hormone therapy nationwide, study results showed.
    “To...More »
  • Industry News
  • European panel: Diane 35's acne benefits outweigh blood clot risks

  • May 17, 2013
  • The benefits of acne drug Diane 35 and its generic equivalents outweigh the risks, provided measures are taken to minimize thromboembolism risk, according...More »
  • In the Journals
  • Survey: Postmenopausal women prefer vaginal tablets to other therapies

  • May 13, 2013
  • In a recent survey, researchers identified reasons for noncompliance regarding local estrogen therapy for vaginal atrophy by asking postmenopausal women...More »
  • FDA advisory panel decisions
  • FDA advisory panel split on safety of testosterone undecanoate

  • April 18, 2013
  • The Reproductive Health Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee weighed in on the safety of testosterone...More »
  • FDA advisory panel decisions
  • FDA advisory panel split on safety of testosterone undecanoate

  • Endocrine Today, May 2013
  • The Reproductive Health Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee weighed in on the safety of testosterone...More »
  • Discontinuation of HT may increase risk for hypertension

  • April 10, 2013
  • After the results of the Women’s Health Initiative more than a decade ago, many patients discontinued hormone therapy or estrogen therapy. New data...More »
  • Discontinuation of HT may increase risk for hypertension

  • Endocrine Today, May 2013
  • After the results of the Women’s Health Initiative more than a decade ago, many patients discontinued hormone therapy or estrogen therapy. New data...More »
  • In the Journals Perspective
  • Estrogen plus progestin increased incidence of breast cancer, mortality

  • April 2, 2013
  • New data suggest that estrogen plus progestin use is linked to increased breast cancer incidence and mortality. These findings are consistent with results...More »
  • Perspective
  • Experts evaluate relevance of disputed data on HT, breast cancer

  • Endocrine Today, April 2013
  • When the results from the Women’s Health Initiative, Collaborative Reanalysis and Million Women Study trials were released more than 10 years ago,...More »
  • In the Journals
  • Parenteral estrogen may reduce hormone agonist toxicity in prostate cancer

  • March 27, 2013
  • Parenteral estrogen patches were associated with encouraging reductions in fasting glucose and cholesterol in a cohort of men with advanced prostate...More »
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • Featured
  • Most Popular
  • In the Journals
  • Rapid decline in ovarian cancer rates coincides with decreased hormone therapy use

  • May 22, 2013
  • Video
  • Hormone therapy and heart disease

  • March 19, 2012
  • Industry News
  • European panel: Diane 35's acne benefits outweigh blood clot risks

  • May 17, 2013
  • Perspective
  • Researchers assess multiple vitamin D doses in healthy breast-fed infants

  • April 30, 2013
  • Health Care Legislative and Regulatory Update
  • BLOG: Inpatient admission or observation services: Do we finally have some clarity?

  • May 20, 2013
  • In the Journals
  • MRI shows greater BMD near bone marrow lesions in patients with OA

  • May 22, 2013

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

View past polls »

Advertisement
  • Resources from Industry
Account Information
  • Create New User
  • Login
  • Subscribe Or Buy
  • Help
Healio.com
  • About Healio
  • Publications
  • Editorial Board
  • Contact the News Desk
  • Contact Us
  • About the Wyanoke Group
  • Advertising Information
  • Reprints
  • Sitemap
Legal
  • Medical Disclaimer
  • Privacy Policy
  • Editorial Policy and Philosophy
  • Terms and Conditions
  • Permissions
Connect with Healio
  • Twitter
  • Facebook
  • RSS Feeds

©2013 All Rights Reserved.

position